Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?" by Märtson, A-G, Boonstra, J M, Sandaradura, I, Kosterink, J G W, van der Werf, T S, Marriott, D J E, Zijlstra, J G, Touw, D J, Alffenaar, J W C

Get full text

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients by Boonstra, J M, Märtson, A G, Sandaradura, I, Kosterink, J G W, van der Werf, T S, Marriott, D J E, Zijlstra, J G, Touw, D J, Alffenaar, J W C

Get full text

The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment by Märtson, A-G., Kim, H. Y., Marais, B., Alffenaar, J-W.

Get full text

Clinical standards for the management of adverse effects during treatment for TB by Singh, K. P., Carvalho, A. C. C., Centis, R., D´Ambrosio, L., Migliori, G. B., Mpagama, S. G., Nguyen, B. C., Aarnoutse, R. E., Aleksa, A., van Altena, R., Bhavani, P. K., Bolhuis, M. S., Borisov, S., van´t Boveneind-Vrubleuskaya, N., Bruchfeld, J., Caminero, J. A., Carvalho, I., Cho, J. G., Davies Forsman, L., Dedicoat, M., Dheda, K., Dooley, K., Furin, J., García-García, J. M., Garcia-Prats, A., Hesseling, A. C., Heysell, S. K., Hu, Y., Kim, H. Y., Manga, S., Marais, B. J., Margineanu, I., Märtson, A-G., Munoz Torrico, M., Nataprawira, H. M., Nunes, E., Ong, C. W. M., Otto-Knapp, R., Palmero, D. J., Peloquin, C. A., Rendon, A., Rossato Silva, D., Ruslami, R., Saktiawati, A. M. I., Santoso, P., Schaaf, H. S., Seaworth, B., Simonsson, U. S. H., Singla, R., Skrahina, A., Solovic, I., Srivastava, S., Stocker, S. L., Sturkenboom, M. G. G., Svensson, E. M., Tadolini, M., Thomas, T. A., Tiberi, S., Trubiano, J., Udwadia, Z. F., Verhage, A. R., Vu, D. H., Akkerman, O. W., Alffenaar, J. W. C., Denholm, J. T.

Get full text

Clinical standards for the dosing and management of TB drugs by Alffenaar, J. W. C., Stocker, S. L., Forsman, L. Davies, Garcia-Prats, A., Heysell, S. K., Aarnoutse, R. E., Akkerman, O. W., Aleksa, A., van Altena, R., de Oñata, W. Arrazola, Bhavani, P. K., van't Boveneind-Vrubleuskaya, N., Carvalho, A. C. C., Centis, R., Chakaya, J. M., Cirillo, D. M., Cho, J. G., D´Ambrosio, L., Dalcolmo, M. P., Denti, P., Dheda, K., Fox, G. J., Hesseling, A. C., Kim, H. Y., Köser, C. U., Marais, B. J., Margineanu, I., Märtson, A. G., Torrico, M. Munoz, Nataprawira, H. M., Ong, C. W. M., Otto-Knapp, R., Peloquin, C. A., Silva, D. R., Ruslami, R., Santoso, P., Savic, R. M., Singla, R., Svensson, E. M., Skrahina, A., van Soolingen, D., Srivastava, S., Tadolini, M., Tiberi, S., Thomas, T. A., Udwadia, Z. F., Vu, D. H., Zhang, W., Mpagama, S. G., Schön, T., Migliori, G. B.

Get full text

Clinical standards for drug-susceptible pulmonary TB by Akkerman, O. W., Duarte, R., Tiberi, S., Schaaf, H. S., Lange, C., Alffenaar, J. W. C., Denholm, J., Carvalho, A. C. C., Bolhuis, M. S., Borisov, S., Bruchfeld, J., Cabibbe, A. M., Caminero, J. A., Carvalho, I., Chakaya, J., Centis, R., Dalcomo, M. P., D´Ambrosio, L., Dedicoat, M., Dheda, K., Dooley, K. E., Furin, J., García-García, J-M., van Hest, N. A. H., de Jong, B. C., Kurhasani, X., Märtson, A. G., Mpagama, S., Torrico, M. Munoz, Nunes, E., Ong, C. W. M., Palmero, D. J., Ruslami, R., Saktiawati, A. M. I., Semuto, C., Silva, D. R., Singla, R., Solovic, I., Srivastava, S., de Steenwinkel, J. E. M., Story, A., Sturkenboom, M. G. G., Tadolini, M., Udwadia, Z. F., Verhage, A. R., Zellweger, J. P., Migliori, G. B.

Get full text

PS-006 Identifying and reporting medication errors helps pharmacists to have a great role in promoting patient safety by Märtson, AG, Saar, M, Kantelhardt, P

Get full text

PS-001 Identification of risk factors frequently associated with medication errors – pan-european project for patient safety (peppas) by Kantelhardt, P, Süle, A, Saar, M, Gudmundsdottir, T, Märtson, AG

Get full text

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE by LASSEN, M. R., FISHER, W., MOURET, P., AGNELLI, G., GEORGE, D., KAKKAR, A., MISMETTI, P., TURPIE, A. G. G.

Get full text

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial by Kakkar, Ajay K, Prof, Brenner, Benjamin, Prof, Dahl, Ola E, MD, Eriksson, Bengt I, MD, Mouret, Patrick, MD, Muntz, Jim, MD, Soglian, Andrea G, MD, Pap, Ákos F, Misselwitz, Frank, MD, Haas, Sylvia, Prof

Get full text